The dehydrogenative alkenylation of C-H bonds with alkenes represents an atom-and stepeconomical approach for olefin synthesis and molecular editing. Site-selective alkenylation of alkanes and aldehydes with the C-H substrate as the limiting reagent holds significant synthetic value. We herein report a photocatalytic method for the direct alkenylation of alkanes and aldehydes with aryl alkenes in the absence of any external oxidant. A diverse range of commodity feedstocks and pharmaceutical compounds are smoothly alkenylated in useful yields with the C-H partner as the limiting reagent. The late-stage alkenylation of complex molecules occurs with high levels of site selectivity for sterically accessible and electron-rich C-H bonds. This strategy relies on the synergistic combination of direct hydrogen atom transfer photocatalysis with cobaloxime-mediated hydrogen-evolution cross-coupling, which promises to inspire additional perspectives for selective C-H functionalizations in a green manner.
Enantioenriched 1,4-dicarbonyl compounds are versatile synthons in natural product and pharmaceutical drug synthesis.W eh erein report am ild pathway for the efficient enantioselective synthesis of these compounds directly from aldehydes through synergistic cooperation between an eutral eosin Yh ydrogen atom transfer photocatalyst and ac hiral rhodium Lewis acid catalyst. This method is distinguished by its operational simplicity,a bundant feedstocks, atom economy,and ability to generate products in high yields (up to 99 %) and high enantioselectivity (up to 99 %ee).Scheme 1. Synthesis of 1,4-dicarbonyl compounds through asymmetric acyl radical conjugateaddition.Supportinginformation and the ORCID identification number(s) for the author(s) of this article can be found under: https://doi.Scheme 5. Gram-scale synthesis and further synthetic diversification.Scheme 6. Proposed reaction mechanism for the merged HATphotocatalysis and asymmetric Lewis acid catalysis. RHAT = reverse hydrogen atom transfer.
Deuterium labelled compounds are of significant importance in chemical mechanism investigations, mass spectrometric studies, diagnoses of drug metabolisms, and pharmaceutical discovery. Herein, we report an efficient hydrogen deuterium exchange reaction...
A visible-light-mediated
radical Smiles rearrangement has been
achieved using neutral eosin Y as a direct hydrogen atom transfer
(HAT) photocatalyst. Novel N-heterocycles as single
diastereomers featuring an isothiazolidin-3-one 1,1-dioxide moiety
are directly accessed by this method. A wide range of functional groups
can be incorporated in the products by employing diverse aldehydes
and N-(hetero)arylsulfonyl propiolamides. The transformation
proceeds through a cascade of visible-light-induced HAT, 1,4-addition,
Smiles rearrangement, 5-endo-trig cyclization, and
a reverse HAT process. Preliminary biological studies of the highly
functionalized heterocyclic compounds suggest potential anticancer
activity with some of the synthesized compounds.
The rational design
of high-performance catalysts is hindered by
the lack of knowledge of the structures of active sites and the reaction
pathways under reaction conditions, which can be ideally addressed
by an
in situ
/
operando
characterization.
Besides the experimental insights, a theoretical investigation that
simulates reaction conditions—so-called
operando
modeling—is necessary for a plausible understanding of a
working catalyst system at the atomic scale. However, there is still
a huge gap between the current widely used computational model and
the concept of
operando
modeling, which should be
achieved through multiscale computational modeling. This Perspective
describes various modeling approaches and machine learning techniques
that step toward
operando
modeling, followed by selected
experimental examples that present an
operando
understanding
in the thermo- and electrocatalytic processes. At last, the remaining
challenges in this area are outlined.
As a new antioxidant, nanoceria is of significant importance in applications of medical and biological fields. In comparison with conventional organic antioxidants, nanoceria has multienzyme mimetic activity by Ce 4+ /Ce 3+ redox cycle. This unique regenerative/autocatalytic property has been widely used in the aspects of free-radical scavenger, radiation protection, oxidativestress-related disease, drug delivery, biosensor, tissue engineering, cancer biomarker, and anti-inflammatory. This paper reviews the latest breakthrough of nanoceria as an antioxidant in applications of medical and biological fields on the base of the authors' research works on resistance to oxidation and cytotoxicity. The challenges of nanoceria encountered in applications in medical and biological fields are commented as well.
While aldehydes represent a classic class of electrophilic synthons, the corresponding acyl radicals are inherently nucleophilic, which exhibits umpolung reactivity. Generation of acyl radicals typically requires noble metal catalysts or excess oxidants to be added. Herein, we report a convenient and green approach to access acyl radicals, capitalizing on neutral eosin Y-enabled hydrogen atom transfer (HAT) photocatalysis with aldehydes. The generated acyl radicals underwent SOMOphilic substitutions with various functionalized sulfones (X–SO2R’) to deliver value-added acyl products. The merger of eosin Y photocatalysis and sulfone-based SOMOphiles provides a versatile platform for a wide array of aldehydic C–H functionalizations, including fluoromethylthiolation, arylthiolation, alkynylation, alkenylation and azidation. The present protocol features green characteristics, such as being free of metals, harmful oxidants and additives; step-economic; redox-neutral; and amenable to scale-up assisted by continuous-flow technology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.